Healthcare Quality, Patient Safety & Policy

ASP Gets CE Mark for ULTRA GI™ Cycle with FUJIFILM

ASP International GmbH (“ASP”), a division of Fortive (NYSE: FTV), in collaboration with FUJIFILM Healthcare Europe GmbH, proudly announces that the ULTRA GI™ Cycle has received CE mark approval. The ULTRA GI™ Cycle is the latest innovation for the STERRAD™ 100NX Sterilizer with ALLClear™ Technology.

The ULTRA GI™ Cycle’s receipt of the CE mark represents a pivotal advancement in elevating patient safety across healthcare facilities and addressing the complex challenges associated with traditional reprocessing methods. “This is a meaningful step forward in our mission to make duodenoscope reprocessing safer across Europe,” said Chad Rohrer, President, ASP. “By bringing hydrogen peroxide gas plasma sterilization into routine practice, we’re giving clinicians greater confidence to focus on what matters most – their patients.” ASP’s immediate focus is to work with medical device manufacturers to ensure that new duodenoscope models are designed to be compatible with hydrogen peroxide. The partnership with FUJIFILM Healthcare Europe is the latest example of this.

Pierre Emeric, Vice President, R&D at ASP, continued, “The addition of the new FUJIFILM duodenoscope models ED-840T and ED-840XT to the ULTRA GI Cycle further expands the breakthrough technology platform and demonstrates ASP’s commitment to innovation and partnership with FUJIFILM Healthcare. Most importantly, current ASP customers who already have a STERRAD 100NX Sterilizer with ALLClear Technology can access the benefits of the ULTRA GI Cycle via a cycle upgrade on their existing equipment and can continue maximizing the value of their investment.”

“Duodenoscopes have historically posed infection control challenges due to their contamination rates,” said Ivan Salgo, MD, VP & Chief Medical Officer at ASP. “The partnership between ASP and FUJIFILM Healthcare has resulted in a sterilization approach that exceeds current industry benchmarks, providing healthcare professionals with an advanced solution to elevate patient safety standards.”

Visit this webpage for more information on the ULTRA GI™ Cycle.

Related posts

WuXi Biologics Wins Hong Kong ESG Reporting Award

PR Newswire

CARsgen Successfully Defends Its GPC3 CAR-T Patent at the EPO

PR Newswire

6th Global Pharma Picks LifeSphere NavaX for GenAI Case Processing

PR Newswire